AMANDA MCKINNEY: Open Payments
NPI 1568813517 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,903 in 151 payments from 23 companies in 2025. Trend: 2023 $1,047 · 2024 $2,867 · 2025 $2,903
Food & beverage: $2,819Education: $84
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 43 | $535 |
| Janssen Biotech, Inc. | 15 | $403 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $257 |
| Ardelyx, Inc. | 11 | $233 |
| Madrigal Pharmaceuticals | 9 | $183 |
| Aimmune Therapeutics, Inc. | 11 | $174 |
| Novo Nordisk Inc | 4 | $160 |
| Enterra Medical, Inc. | 1 | $158 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $124 |
| Lilly USA, LLC | 6 | $99 |
Products named: TREMFYA, RINVOQ, ENTYVIO, IBSRELA, REZDIFFRA, Wegovy, XIFAXAN, DUPIXENT.
Industry payments across TN — which companies pay providers there.
